By Richard Lowe2021-01-26T14:00:00+00:00
Oxford Properties Group, the real estate arm of Canadian pension fund OMERS, has confirmed that it is buying European fund manager M7 Real Estate.
The C$80bn (€51bn) real estate investor said it was making the acquisition as part of plans to deploy £3bn (€3.33bn) into multi-let industrial and urban logistics across Europe.
M7 Real Estate, which manages about €4bn of assets on behalf of third-party investors, will continue to operate as a standalone business, led by co-founders Richard Croft and David Ebbrell.
Under the new ownership, the company will have access to a greater pool of capital for both real estate and corporate investments.
(Bloomberg) Ontario Municipal Employees’ Retirement System almost quadrupled its stock holdings in Asia-Pacific last year and plans to keep boosting its exposure to the fast-growing region over the next several years.
Oxford Properties Buys 4 Life Sciences Buildings
Posted on 01/12/2021
Oxford Properties Group, the real estate unit of Ontario Municipal Employees Retirement System, acquired four life sciences assets totaling 415,000 square feet, and developable land for US$ 276 million, with anticipated follow on investments of US$ 500 million in the assets. The acquisitions come as part of Oxford’s strategy to build a life sciences business in an asset class. Oxford intends to deploy an additional US$ 500 million of capital into these investments through development of new biotech space and converting existing office and retail uses into new lab space at the Bay Area asset and has identified value-add opportunities within the Boston portfolio.
Oxford Properties Group, the real estate investment arm of OMERS, has acquired four life sciences assets totaling 415,000 square feet and developable land for $276 million.
Oxford Properties Group is perpetuating the Bay Area and Boston-area life sciences boom with a move worth more than a quarter of a billion dollars, and it plans to use another half-billion on further capital investments.
The Toronto-based investment company and developer paid $276M for four life sciences assets and plots of land suitable for development in the thriving life sciences sector, according to a press release.
The deal comprises a mixed-use property in the East Bay city of Emeryville that also includes two land parcels earmarked for life sciences development, as well as three properties around Boston. Oxford expects to bolster the bundle by making additional capital investments amounting to $500M.